STEVEN HSU, M.D.
Advanced Heart Failure and Transplant Cardiology Physician in BALTIMORE, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
STEVEN HSU, M.D. reported a CMS MIPS final score of 74.3962/100 — below the 83.1 national average — and filed 864 Medicare Part D claims in 2023.
- 74.3962/100
- MIPS score · -9 vs avg
- 864
- Part D claims, 2023
- 65%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
STEVEN HSU, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
74 12th percentile higher than 12% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
STEVEN HSU, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 3 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about STEVEN HSU, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Maryland
How Advanced Heart Failure and Transplant Cardiology Physician compares to other specialties among Maryland providers
Advanced Heart Failure and Transplant Cardiology Physician share within Maryland
Advanced Heart Failure and Transplant Cardiology Physician is one of the more visible NUCC categories in Maryland
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
STEVEN HSU, M.D.'s 2023 MIPS final score plotted against the Advanced Heart Failure and Transplant Cardiology Physician national average
- MIPS Final Score
- 74.3962/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Advanced Heart Failure and Transplant Cardiology Physician) — 74.3962/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Advanced Heart Failure and Transplant Cardiology Physician US NPIs
74.3962/100 MIPS final score — 8.7 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Advanced Heart Failure and Transplant Cardiology Physician. Quality dim: 64.7185. Cost dim: 52.4354.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
STEVEN HSU, M.D. appears in the CMS NPPES registry as a Advanced Heart Failure and Transplant Cardiology Physician provider holding M.D. credentials at 600 N WOLFE ST, BALTIMORE, MD, 21287, with a listed phone of (410) 955-7963. NPI 1669615324 was issued on 04/10/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HSU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 864 prescription claims written by this provider, covering 107 Medicare beneficiaries and totaling roughly $398K in drug spend, split 35% brand-name and 65% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.3962/100 for the 2023 performance year (Quality 64.7185, Cost 52.4354), compared with the national average of 83.1.
Advanced Heart Failure and Transplant Cardiology Physician is a narrow specialty nationwide, with 510 enrolled providers across 48 states and an average of 1,762 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1669615324 |
|---|---|
| Specialty | Advanced Heart Failure and Transplant Cardiology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/10/2009 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm STEVEN HSU, M.D.'s current license status, disciplinary history, and board certifications with the Maryland Board of Physicians in Maryland before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where STEVEN HSU, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Above average
35% brand-name claims vs 65% generic, on 864 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,132
- Total Day Supply
- 63,819
- Brand vs Generic
- 35% brand / 65% generic
- Brand Drug Cost
- $382K
- Generic Drug Cost
- $16K
Patient Demographics
- Average Patient Age
- 69.3 years
- Avg HCC Risk Score
- 2.48
- Gender Split
- 42% female / 58% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What STEVEN HSU, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Entresto
Entresto
112 claims
- Spironolactone
Spironolactone
81 claims
- Carvedilol
Carvedilol
79 claims
- Metoprolol Succinate
Metoprolol Succinate
64 claims
- Farxiga
Farxiga
63 claims
- Jardiance
Jardiance
56 claims
- Torsemide
Torsemide
55 claims
- Eliquis
Eliquis
45 claims
| Drug | Claims |
|---|---|
| Entresto Sacubitril/Valsartan | 112 |
| Spironolactone | 81 |
| Carvedilol | 79 |
| Metoprolol Succinate | 64 |
| Farxiga Dapagliflozin Propanediol | 63 |
| Jardiance Empagliflozin | 56 |
| Torsemide | 55 |
| Eliquis Apixaban | 45 |
| Atorvastatin Calcium | 35 |
| Furosemide | 23 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Advanced Heart Failure and Transplant Cardiology Physician Overview
How STEVEN HSU, M.D. fits within the Advanced Heart Failure and Transplant Cardiology Physician landscape nationally.
STEVEN HSU, M.D.'s 864 claims are below the specialty average of 1,762.
Nearby Advanced Heart Failure and Transplant Cardiology Physician Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as HSU.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Maryland
Frequently Asked Questions
What is STEVEN HSU, M.D.'s specialty? ▼
How much does STEVEN HSU, M.D. prescribe under Medicare Part D? ▼
What is STEVEN HSU, M.D.'s Medicare quality score? ▼
Where is STEVEN HSU, M.D. located? ▼
What is STEVEN HSU, M.D.'s NPI number? ▼
Does STEVEN HSU, M.D. prescribe more brand-name or generic drugs? ▼
How many Advanced Heart Failure and Transplant Cardiology Physician providers are there in the US? ▼
What drugs does STEVEN HSU, M.D. prescribe most often? ▼
Does STEVEN HSU, M.D. accept Medicare? ▼
How can I verify STEVEN HSU, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology